A 12-year prospective study of the relationship between islet antibodies and beta-cell function at and after the diagnosis in patients with adult-onset diabetes.
(2002) In Diabetes 51(6). p.1754-1762- Abstract
- To clarify the relationships between islet antibodies (islet cell antibody [ICA], GAD antibody [GADA], and IA-2 antibody [IA-2A]) versus the progression of beta-cell dysfunction, we have followed a group of diabetic patients from their diagnosis at 21-73 years of age. Patients with ICA had high levels of GADA and/or IA-2A at diagnosis and a more severe beta-cell dysfunction 5 years after diagnosis than those with only GADA in low concentrations. The aim of the current 12-year follow-up study was to examine the further progression of beta-cell dysfunction in relation to islet antibodies at and after diagnosis. Among 107 patients, complete beta-cell failure 12 years after diagnosis was restricted to those with islet antibodies at diagnosis... (More)
- To clarify the relationships between islet antibodies (islet cell antibody [ICA], GAD antibody [GADA], and IA-2 antibody [IA-2A]) versus the progression of beta-cell dysfunction, we have followed a group of diabetic patients from their diagnosis at 21-73 years of age. Patients with ICA had high levels of GADA and/or IA-2A at diagnosis and a more severe beta-cell dysfunction 5 years after diagnosis than those with only GADA in low concentrations. The aim of the current 12-year follow-up study was to examine the further progression of beta-cell dysfunction in relation to islet antibodies at and after diagnosis. Among 107 patients, complete beta-cell failure 12 years after diagnosis was restricted to those with islet antibodies at diagnosis (16 of 21 [77%] with multiple antibodies and 4 of 5 [80%] with only GADA). In contrast, among antibody-negative patients, fasting P-C-peptide levels were unchanged. Most GADA-positive patients (22 of 27 [81%]) remained GADA positive after 12 years. Associated with decreasing fasting P-C-peptide levels (0.85 nmol/l [0.84] at diagnosis vs. 0.51 nmol/l [0.21] 12 years after diagnosis, P < 0.05), ICA developed after diagnosis in 6 of 105 originally antibody negative mostly overweight patients. In conclusion, multiple islet antibodies or GADA alone at diagnosis of diabetes predict future complete beta-cell failure. After diagnosis, GADA persisted in most patients, whereas ICA development in patients who were antibody negative at diagnosis indicated decreasing beta-cell function. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/108547
- author
- Borg, Henrik LU ; Gottsäter, Anders LU ; Fernlund, Per LU and Sundkvist, Göran LU
- organization
- publishing date
- 2002
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Diabetes Mellitus, Islets of Langerhans : immunology, Human, Islets of Langerhans : physiopathology, Isoenzymes : immunology, Middle Age, Prognosis, Prospective Studies, Support, Non-U.S. Gov't, Glutamate Decarboxylase : immunology, Non-Insulin-Dependent : physiopathology, Fasting, Non-Insulin-Dependent : immunology, Non-Insulin-Dependent : diagnosis, Adult, Aged, Autoantibodies : blood, C-Peptide : blood
- in
- Diabetes
- volume
- 51
- issue
- 6
- pages
- 1754 - 1762
- publisher
- American Diabetes Association Inc.
- external identifiers
-
- pmid:12031962
- wos:000175936700013
- scopus:0036266123
- ISSN
- 1939-327X
- DOI
- 10.2337/diabetes.51.6.1754
- language
- English
- LU publication?
- yes
- additional info
- The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Endocrinology (013241500), Unit for Clinical Vascular Disease Research (013242410), Clinical Chemistry, Malmö (013016000), Pediatrics/Urology/Gynecology/Endocrinology (013240400)
- id
- a94b1cfb-e156-4423-9b94-39b9fd5b6bfe (old id 108547)
- alternative location
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12031962&dopt=Abstract
- date added to LUP
- 2016-04-01 16:10:11
- date last changed
- 2022-04-22 20:04:08
@article{a94b1cfb-e156-4423-9b94-39b9fd5b6bfe, abstract = {{To clarify the relationships between islet antibodies (islet cell antibody [ICA], GAD antibody [GADA], and IA-2 antibody [IA-2A]) versus the progression of beta-cell dysfunction, we have followed a group of diabetic patients from their diagnosis at 21-73 years of age. Patients with ICA had high levels of GADA and/or IA-2A at diagnosis and a more severe beta-cell dysfunction 5 years after diagnosis than those with only GADA in low concentrations. The aim of the current 12-year follow-up study was to examine the further progression of beta-cell dysfunction in relation to islet antibodies at and after diagnosis. Among 107 patients, complete beta-cell failure 12 years after diagnosis was restricted to those with islet antibodies at diagnosis (16 of 21 [77%] with multiple antibodies and 4 of 5 [80%] with only GADA). In contrast, among antibody-negative patients, fasting P-C-peptide levels were unchanged. Most GADA-positive patients (22 of 27 [81%]) remained GADA positive after 12 years. Associated with decreasing fasting P-C-peptide levels (0.85 nmol/l [0.84] at diagnosis vs. 0.51 nmol/l [0.21] 12 years after diagnosis, P < 0.05), ICA developed after diagnosis in 6 of 105 originally antibody negative mostly overweight patients. In conclusion, multiple islet antibodies or GADA alone at diagnosis of diabetes predict future complete beta-cell failure. After diagnosis, GADA persisted in most patients, whereas ICA development in patients who were antibody negative at diagnosis indicated decreasing beta-cell function.}}, author = {{Borg, Henrik and Gottsäter, Anders and Fernlund, Per and Sundkvist, Göran}}, issn = {{1939-327X}}, keywords = {{Diabetes Mellitus; Islets of Langerhans : immunology; Human; Islets of Langerhans : physiopathology; Isoenzymes : immunology; Middle Age; Prognosis; Prospective Studies; Support; Non-U.S. Gov't; Glutamate Decarboxylase : immunology; Non-Insulin-Dependent : physiopathology; Fasting; Non-Insulin-Dependent : immunology; Non-Insulin-Dependent : diagnosis; Adult; Aged; Autoantibodies : blood; C-Peptide : blood}}, language = {{eng}}, number = {{6}}, pages = {{1754--1762}}, publisher = {{American Diabetes Association Inc.}}, series = {{Diabetes}}, title = {{A 12-year prospective study of the relationship between islet antibodies and beta-cell function at and after the diagnosis in patients with adult-onset diabetes.}}, url = {{http://dx.doi.org/10.2337/diabetes.51.6.1754}}, doi = {{10.2337/diabetes.51.6.1754}}, volume = {{51}}, year = {{2002}}, }